EPO and anemia (phenotype): Moreover, l-carnitine administration has been reported to be effective in increasing the red blood cell lifespan through improvement of the erythrocyte membrane fat metabolism [3], improvement of erythrocyte cell membrane stabilization [18], and erythropoietin low-responsiveness anemia in renal diseases [13,19].